Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,443 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Completed

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

NCT03314935

Conditions
Adnexal Diseases, Biliary Tract Cancer (BTC), Biliary Tract Diseases, +32 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • USA Mitchell Cancer Center Mobile, Alabama, United States
  • UC Davis - Comprehensive Cancer Centre Sacramento, California, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
View Trial Details
Completed

A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

NCT03395080

Conditions
Adnexal Diseases, Carcinosarcoma, Endocrine Gland Neoplasms, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • HonorHealth Scottsdale, Arizona, United States
  • Florida Cancer Specialists & Research Institute West Palm Beach, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

Trial in Patients With Relapsed Ovarian Cancer

NCT03267589

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Rigshospitalet København Ø, Region Sjælland, Denmark
  • VejleSygehus Vejle, Region Syddanmark, Denmark
  • Tampere University Hospital Tampere, Finland
  • Haukeland University Hospital Bergen, Haukeland, Norway
View Trial Details
Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316

Conditions
AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Stanford, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Aurora, Colorado, United States
View all 34 locations
View Trial Details

Related conditions